Predictors of treatment failure for adenocarcinoma

adenocarcinoma-in-situ margin status papillomavirus infection treatment failure

Journal

Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 17 06 2022
accepted: 26 07 2022
entrez: 28 9 2022
pubmed: 29 9 2022
medline: 29 9 2022
Statut: epublish

Résumé

The incidence of adenocarcinoma-

Identifiants

pubmed: 36168314
doi: 10.3892/ol.2022.13477
pii: OL-24-04-13477
pmc: PMC9478621
doi:

Types de publication

Journal Article

Langues

eng

Pagination

357

Informations de copyright

Copyright: © Belkić et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Gynecol Oncol. 2000 Aug;78(2):97-105
pubmed: 10926787
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):109-113
pubmed: 33507893
Obstet Gynecol. 2020 Apr;135(4):869-878
pubmed: 32168211
Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:68-73
pubmed: 31234059
J Womens Health (Larchmt). 2017 Jun;26(6):609-615
pubmed: 28332888
Oncol Lett. 2021 Sep;22(3):684
pubmed: 34434283
BMC Public Health. 2016 Aug 19;16:832
pubmed: 27538390
Vaccine. 2012 Nov 20;30 Suppl 5:F88-99
pubmed: 23199969
Int J Cancer. 2020 Feb 1;146(3):810-818
pubmed: 30980692
Gynecol Oncol. 2014 Dec;135(3):468-73
pubmed: 25284039
Cancer. 2019 Jan 15;125(2):239-248
pubmed: 30536370
J Med Screen. 2021 Jun;28(2):213-216
pubmed: 33730899
Lancet Oncol. 2017 Dec;18(12):1665-1679
pubmed: 29126708
BMJ. 2016 Feb 11;352:i276
pubmed: 26869597
Gynecol Oncol. 2012 May;125(2):500-7
pubmed: 22266548
Am J Obstet Gynecol. 2009 Jul;201(1):17.e1-8
pubmed: 19344881
Gynecol Oncol. 2013 Jun;129(3):513-6
pubmed: 23541795
Int J Gynecol Cancer. 2014 Nov;24(9):1543-8
pubmed: 25238167
PLoS One. 2018 Jun 18;13(6):e0199038
pubmed: 29912903
J Clin Virol. 2013 Oct;58(2):432-6
pubmed: 24008206
Am J Obstet Gynecol. 2009 Feb;200(2):182.e1-5
pubmed: 19019325
Aust N Z J Obstet Gynaecol. 2020 Feb;60(1):123-129
pubmed: 31578727
Curr Treat Options Oncol. 2004 Apr;5(2):119-27
pubmed: 14990206
Am J Obstet Gynecol. 2020 Feb;222(2):172.e1-172.e12
pubmed: 31473226
BMC Public Health. 2016 Aug 24;16(1):868
pubmed: 27557928
Pathobiology. 2021;88(1):46-55
pubmed: 32634799
Int J Cancer. 2002 Mar 20;98(3):435-9
pubmed: 11920596
Int J Gynaecol Obstet. 2018 Sep;142(3):359-364
pubmed: 29856071
J Clin Virol. 2016 Sep;82:46-50
pubmed: 27434147
Cancer. 2004 Mar 1;100(5):1035-44
pubmed: 14983500
Acta Obstet Gynecol Scand. 2018 Jun;97(6):758-765
pubmed: 29430635
Int J Gynecol Cancer. 2020 Aug;30(8):1097-1100
pubmed: 32487685
Infect Agent Cancer. 2020 Oct 14;15:61
pubmed: 33072179
Lancet Oncol. 2010 Nov;11(11):1048-56
pubmed: 20952254
Acta Cytol. 2012;56(2):155-9
pubmed: 22378077
Oncol Rep. 2012 Jul;28(1):346-52
pubmed: 22484610
J Natl Cancer Inst. 2021 Jun 1;113(6):662-664
pubmed: 32609333
Gynecol Oncol. 2012 Mar;124(3):490-5
pubmed: 22188786
Gynecol Oncol. 2007 Jul;106(1):170-6
pubmed: 17481701
Am J Obstet Gynecol. 2007 Aug;197(2):195.e1-7; discussion 195.e7-8
pubmed: 17689647
Acta Obstet Gynecol Scand. 2013 Jul;92(7):830-40
pubmed: 23530870
J Rural Health. 2016 Spring;32(2):136-45
pubmed: 26265118
Acta Obstet Gynecol Scand. 2003 Oct;82(10):960-5
pubmed: 12956848
Am J Obstet Gynecol. 2020 Sep;223(3):372-378
pubmed: 32522513
Oncol Lett. 2021 Apr;21(4):240
pubmed: 33664804
BMJ Open. 2017 Dec 14;7(12):e017070
pubmed: 29247086
Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:26-30
pubmed: 25956340
J Cancer Educ. 2021 Feb;36(1):126-133
pubmed: 31522376
Clin Microbiol Infect. 2015 Sep;21(9):817-26
pubmed: 25936581
Cancer. 2021 Feb 15;127(4):498-503
pubmed: 33170520
J Community Health. 2014 Oct;39(5):849-56
pubmed: 25120228
Br J Cancer. 2021 Apr;124(9):1516-1523
pubmed: 33723386
Lancet Oncol. 2014 Feb;15(2):172-83
pubmed: 24433684
Int J Gynecol Pathol. 2009 May;28(3):272-8
pubmed: 19620946
J Ovarian Res. 2020 Sep 11;13(1):105
pubmed: 32917254
Arch Pathol Lab Med. 2015 Nov;139(11):1431-6
pubmed: 25951104
Public Health Res Pract. 2020 Dec 9;30(4):
pubmed: 33294902
Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:236-241
pubmed: 28068597

Auteurs

Karen Belkić (K)

Department of Oncology-Pathology, Karolinska Institute, SE-17176 Stockholm, Sweden.
School of Community/Global Health, Claremont Graduate University, Claremont, CA 91711, USA.
Institute for Health Promotion and Disease Prevention Research, Keck School of Medicine, University of Southern California, Los Angeles, CA 90032, USA.

Sonia Andersson (S)

Department of Women's and Children's Health, Obstetrics-Gynecology Division, Karolinska Institute, Stockholm, SE-17176 Stockholm, Sweden.

Susanna Alder (S)

Department of Women's and Children's Health, Obstetrics-Gynecology Division, Karolinska Institute, Stockholm, SE-17176 Stockholm, Sweden.

Miriam Mints (M)

Department of Women's and Children's Health, Obstetrics-Gynecology Division, Karolinska Institute, Stockholm, SE-17176 Stockholm, Sweden.
Department of Gynecology and Obstetrics, School of Medical Sciences, Faculty of Medicine-Health, Örebrö University, SE-70182 Örebrö, Sweden.

David Megyessi (D)

Department of Women's and Children's Health, Obstetrics-Gynecology Division, Karolinska Institute, Stockholm, SE-17176 Stockholm, Sweden.

Classifications MeSH